{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["free radicals", "ginsenosides", "gut microbiota", "herbal products", "medicinal plants", "saponins"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38999868", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "13"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": ["2120", "10.3390/nu16132120"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "02"}], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "16", "Issue": "13", "PubDate": {"Year": "2024", "Month": "Jul", "Day": "02"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "<i>Panax notoginseng</i>: Pharmacological Aspects and Toxicological Issues.", "Abstract": {"AbstractText": ["Current evidence suggests a beneficial role of herbal products in free radical-induced diseases. <i>Panax notoginseng</i> (Burk.) F. H. Chen has long occupied a leading position in traditional Chinese medicine because of the ergogenic, nootropic, and antistress activities, although these properties are also acknowledged in the Western world. The goal of this paper is to review the pharmacological and toxicological properties of <i>P. notoginseng</i> and discuss its potential therapeutic effect. A literature search was carried out on Pubmed, Scopus, and the Cochrane Central Register of Controlled Trials databases. The following search terms were used: \"notoginseng\", \"gut microbiota\", \"immune system\", \"inflammation\", \"cardiovascular system\", \"central nervous system\", \"metabolism\", \"cancer\", and \"toxicology\". Only peer-reviewed articles written in English, with the full text available, have been included. Preclinical evidence has unraveled the <i>P. notoginseng</i> pharmacological effects in immune-inflammatory, cardiovascular, central nervous system, metabolic, and neoplastic diseases by acting on several molecular targets. However, few clinical studies have confirmed the therapeutic properties of <i>P. notoginseng</i>, mainly as an adjuvant in the conventional treatment of cardiovascular disorders. Further clinical studies, which both confirm the efficacy of <i>P. notoginseng</i> in free radical-related diseases and delve into its toxicological aspects, are mandatory to broaden its therapeutic potential."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo F. Vito 1, 00168 Rome, Italy."}, {"Identifier": [], "Affiliation": "Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Universit\u00e0 Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy."}], "LastName": "Mancuso", "ForeName": "Cesare", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Panax notoginseng"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Cardiovascular Diseases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": ["methods"], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}], "CoiStatement": "The author declares no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Dennehy C.E., Tsourounis C. Botanicals (\u201cHerbal medications\u201d) & nutritional supplements. In: Katzung B.G., editor. Basic & Clinical Pharmacology. 8th ed. Lange Medical Books/McGraw-Hill; New York, NY, USA: 2001. pp. 1088\u20131103."}, {"Citation": "Tayeb B.A., Kusuma I.Y., Osman A.A.M., Minorics R. Herbal compounds as promising therapeutic agents in precision medicine strategies for cancer: A systematic review. J. Integr. Med. 2024;22:137\u2013162. doi: 10.1016/j.joim.2024.02.001.", "ArticleIdList": ["10.1016/j.joim.2024.02.001", "38462407"]}, {"Citation": "de Waure C., Bertola C., Baccarini G., Chiavarini M., Mancuso C. Exploring the contribution of curcumin to cancer therapy: A systematic review of randomized controlled trials. Pharmaceutics. 2023;15:1275. doi: 10.3390/pharmaceutics15041275.", "ArticleIdList": ["10.3390/pharmaceutics15041275", "PMC10144810", "37111761"]}, {"Citation": "Gruji\u0107-Milanovi\u0107 J., Rajkovi\u0107 J., Milanovi\u0107 S., Ja\u0107evi\u0107 V., Miloradovi\u0107 Z., Ne\u017ei\u0107 L., Novakovi\u0107 R. Natural substances vs. approved drugs in the treatment of main cardiovascular disorders-Is there a breakthrough? Antioxidants. 2023;12:2088. doi: 10.3390/antiox12122088.", "ArticleIdList": ["10.3390/antiox12122088", "PMC10740850", "38136208"]}, {"Citation": "Islam A., Mishra A., Ahsan R., Fareha S. Phytopharmaceuticals and herbal approaches to target neurodegenerative disorders. Drug Res. 2023;73:388\u2013407. doi: 10.1055/a-2076-7939.", "ArticleIdList": ["10.1055/a-2076-7939", "37308092"]}, {"Citation": "Rahman M.M., Islam M.R., Shohag S., Hossain M.E., Rahaman M.S., Islam F., Ahmed M., Mitra S., Khandaker M.U., Idris A.M., et al. The multifunctional role of herbal products in the management of diabetes and obesity: A comprehensive review. Molecules. 2022;27:1713. doi: 10.3390/molecules27051713.", "ArticleIdList": ["10.3390/molecules27051713", "PMC8911649", "35268815"]}, {"Citation": "Mhillaj E., Cuomo V., Trabace L., Mancuso C. The heme oxygenase/biliverdin reductase system as effector of the neuroprotective outcomes of herb-based nutritional supplements. Front. Pharmacol. 2019;10:1298. doi: 10.3389/fphar.2019.01298.", "ArticleIdList": ["10.3389/fphar.2019.01298", "PMC6859463", "31780933"]}, {"Citation": "Mancuso C., Santangelo R. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food. Chem. Toxicol. 2017;107:362\u2013372. doi: 10.1016/j.fct.2017.07.019.", "ArticleIdList": ["10.1016/j.fct.2017.07.019", "PMC7116968", "28698154"]}, {"Citation": "Mancuso C., Santangelo R. Ferulic acid: Pharmacological and toxicological aspects. Food. Chem. Toxicol. 2014;65:185\u2013195. doi: 10.1016/j.fct.2013.12.024.", "ArticleIdList": ["10.1016/j.fct.2013.12.024", "24373826"]}, {"Citation": "Mancuso C., Siciliano R., Barone E., Preziosi P. Natural substances and Alzheimer\u2019s disease: From preclinical studies to evidence based medicine. Biochim. Biophys. Acta. 2012;1822:616\u2013624. doi: 10.1016/j.bbadis.2011.09.004.", "ArticleIdList": ["10.1016/j.bbadis.2011.09.004", "21939756"]}, {"Citation": "Botanicals.  [(accessed on 8 April 2024)].  Available online:  https://www.efsa.europa.eu/en/topics/topic/botanicals."}, {"Citation": "Botanical Medicine.  [(accessed on 8 April 2024)].  Available online:  https://www.takingcharge.csh.umn.edu/10-top-best-selling-botanicals-what-they-do."}, {"Citation": "Baeg I.H., So S.H. The world ginseng market and the ginseng (Korea) J. Ginseng Res. 2013;37:1\u20137. doi: 10.5142/jgr.2013.37.1.", "ArticleIdList": ["10.5142/jgr.2013.37.1", "PMC3659626", "23717152"]}, {"Citation": "Yun T.K. Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci. 2001;16:S3\u2013S5. doi: 10.3346/jkms.2001.16.S.S3.", "ArticleIdList": ["10.3346/jkms.2001.16.S.S3", "PMC3202213", "11748372"]}, {"Citation": "Xu C., Wang W., Wang B., Zhang T., Cui X., Pu Y., Li N. Analytical methods and biological activities of Panax notoginseng saponins: Recent trends. J. Ethnopharmacol. 2019;236:443\u2013465. doi: 10.1016/j.jep.2019.02.035.", "ArticleIdList": ["10.1016/j.jep.2019.02.035", "30802611"]}, {"Citation": "Global Notoginseng Suppliers.  [(accessed on 25 January 2024)].  Available online:  https://www.thetradevision.com/global/notoginseng-suppliers."}, {"Citation": "Global Notoginseng Root Extract Market Report.  [(accessed on 25 January 2024)].  Available online:  https://www.marketresearchintellect.com/product/global-notoginseng-root-extract-market-size-and-forecast."}, {"Citation": "Liu H., Lu X., Hu Y., Fan X. Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy. Pharmacol. Res. 2020;161:105263. doi: 10.1016/j.phrs.2020.105263.", "ArticleIdList": ["10.1016/j.phrs.2020.105263", "33127555"]}, {"Citation": "Chen W., Dang Y., Zhu C. Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic study. Chin. Med. 2010;5:12. doi: 10.1186/1749-8546-5-12.", "ArticleIdList": ["10.1186/1749-8546-5-12", "PMC2848657", "20331853"]}, {"Citation": "Wang T., Guo R., Zhou G., Zhou X., Kou Z., Sui F., Li C., Tang L., Wang Z. Traditional uses, botany, phytochemistry, pharmacology and toxicology of Panax notoginseng (Burk.) F.H. Chen: A review. J. Ethnopharmacol. 2016;188:234\u2013258. doi: 10.1016/j.jep.2016.05.005.", "ArticleIdList": ["10.1016/j.jep.2016.05.005", "27154405"]}, {"Citation": "Yang W.Z., Hu Y., Wu W.Y., Ye M., Guo D.A. Saponins in the genus Panax L. (Araliaceae): A systematic review of their chemical diversity. Phytochemistry. 2014;106:7\u201324. doi: 10.1016/j.phytochem.2014.07.012.", "ArticleIdList": ["10.1016/j.phytochem.2014.07.012", "25108743"]}, {"Citation": "Kim D.H. Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J. Ginseng Res. 2012;36:1\u201315. doi: 10.5142/jgr.2012.36.1.1.", "ArticleIdList": ["10.5142/jgr.2012.36.1.1", "PMC3659563", "23717099"]}, {"Citation": "Liu J., Wang Y., Qiu L., Yu Y., Wang C. Saponins of Panax notoginseng: Chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases. Expert. Opin. Investig. Drugs. 2014;23:523\u2013539. doi: 10.1517/13543784.2014.892582.", "ArticleIdList": ["10.1517/13543784.2014.892582", "24555869"]}, {"Citation": "Xiong Y., Halima M., Che X., Zhang Y., Schaaf M.J.M., Li M., Gao M., Guo L., Huang Y., Cui X., et al. Steamed Panax notoginseng and its saponins inhibit the migration and induce the apoptosis of neutrophils in a zebrafish tail-fin amputation model. Front. Pharmacol. 2022;13:946900. doi: 10.3389/fphar.2022.946900.", "ArticleIdList": ["10.3389/fphar.2022.946900", "PMC9302486", "35873541"]}, {"Citation": "Sun S., Qi L.W., Du G.J., Mehendale S.R., Wang C.Z., Yuan C.S. Red notoginseng: Higher ginsenoside content and stronger anticancer potential than Asian and American ginseng. Food. Chem. 2011;125:1299\u20131305. doi: 10.1016/j.foodchem.2010.10.049.", "ArticleIdList": ["10.1016/j.foodchem.2010.10.049", "PMC3041968", "21344064"]}, {"Citation": "Xiong Y., Chen L., Man J., Hu Y., Cui X. Chemical and bioactive comparison of Panax notoginseng root and rhizome in raw and steamed forms. J. Ginseng Res. 2019;43:385\u2013393. doi: 10.1016/j.jgr.2017.11.004.", "ArticleIdList": ["10.1016/j.jgr.2017.11.004", "PMC6606817", "31308810"]}, {"Citation": "Liu C., Zuo Z., Xu F., Wang Y. Study of the suitable climate factors and geographical origins traceability of Panax notoginseng based on correlation analysis and spectral images combined with machine learning. Front. Plant. Sci. 2023;13:1009727. doi: 10.3389/fpls.2022.1009727.", "ArticleIdList": ["10.3389/fpls.2022.1009727", "PMC9941628", "36825249"]}, {"Citation": "Xu Y., Zhu M., Feng Y., Xu H. Panax notoginseng-microbiota interactions: From plant cultivation to medicinal application. Phytomedicine. 2023;119:154978. doi: 10.1016/j.phymed.2023.154978.", "ArticleIdList": ["10.1016/j.phymed.2023.154978", "37549538"]}, {"Citation": "Dennehy C.E., Tsourounis C.T. Dietary supplements & herbal medications. In: Katzung B.G., Vanderah T.W., editors. Basic & Clinical Pharmacology. 15th ed. McGraw-Hill; New York, NY, USA: 2021. pp. 1179\u20131194."}, {"Citation": "Lee J., Lee E., Kim D., Lee J., Yoo J., Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J. Ethnopharmacol. 2009;122:143\u2013148. doi: 10.1016/j.jep.2008.12.012.", "ArticleIdList": ["10.1016/j.jep.2008.12.012", "19146939"]}, {"Citation": "Wang H.Y., Qi L.W., Wang C.Z., Li P. Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosides. Am. J. Chin. Med. 2011;39:1103\u20131115. doi: 10.1142/S0192415X11009433.", "ArticleIdList": ["10.1142/S0192415X11009433", "PMC3349338", "22083984"]}, {"Citation": "Hu Z., Yang J., Cheng C., Huang Y., Du F., Wang F., Niu W., Xu F., Jiang R., Gao X., et al. Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi) Drug. Metab. Dispos. 2013;41:1457\u20131469. doi: 10.1124/dmd.113.051391.", "ArticleIdList": ["10.1124/dmd.113.051391", "23649704"]}, {"Citation": "Wang S., Song F., Gu H., Shu Z., Wei X., Zhang K., Zhou Y., Jiang L., Wang Z., Li J., et al. Assess the diversity of gut microbiota among healthy adults for forensic application. Microb. Cell. Fact. 2022;21:46. doi: 10.1186/s12934-022-01769-6.", "ArticleIdList": ["10.1186/s12934-022-01769-6", "PMC8944125", "35331204"]}, {"Citation": "Zhang H.Y., Niu W., Olaleye O.E., Du F.F., Wang F.Q., Huang Y.H., Yuan L., Li Y.F., Liu G.P., Xu F., et al. Comparison of intramuscular and intravenous pharmacokinetics of ginsenosides in humans after dosing XueShuanTong, a lyophilized extract of Panax notoginseng roots. J. Ethnopharmacol. 2020;253:112658. doi: 10.1016/j.jep.2020.112658.", "ArticleIdList": ["10.1016/j.jep.2020.112658", "32035876"]}, {"Citation": "Pintusophon S., Niu W., Duan X.N., Olaleye O.E., Huang Y.H., Wang F.Q., Li Y.F., Yang J.L., Li C. Intravenous formulation of Panax notoginseng root extract: Human pharmacokinetics of ginsenosides and potential for perpetrating drug interactions. Acta. Pharmacol. Sin. 2019;40:1351\u20131363. doi: 10.1038/s41401-019-0273-1.", "ArticleIdList": ["10.1038/s41401-019-0273-1", "PMC6786404", "31358899"]}, {"Citation": "Qi L.W., Wang C.Z., Du G.J., Zhang Z.Y., Calway T., Yuan C.S. Metabolism of ginseng and its interactions with drugs. Curr. Drug. Metab. 2011;12:818\u2013822. doi: 10.2174/138920011797470128.", "ArticleIdList": ["10.2174/138920011797470128", "PMC3291795", "21619519"]}, {"Citation": "Rhule A., Rase B., Smith J.R., Shepherd D.M. Toll-like receptor ligand-induced activation of murine DC2.4 cells is attenuated by Panax notoginseng. J. Ethnopharmacol. 2008;116:179\u2013186. doi: 10.1016/j.jep.2007.11.019.", "ArticleIdList": ["10.1016/j.jep.2007.11.019", "PMC2265075", "18164154"]}, {"Citation": "Wang Q.H., Kuang N., Hu W.Y., Yin D., Wei Y.Y., Hu T.J. The effect of Panax notoginseng saponins on oxidative stress induced by PCV2 infection in immune cells: In vitro and in vivo studies. J. Vet. Sci. 2020;21:e61. doi: 10.4142/jvs.2020.21.e61.", "ArticleIdList": ["10.4142/jvs.2020.21.e61", "PMC7402940", "32735098"]}, {"Citation": "Yi H., Yu Z., Wang Q., Sun Y., Peng J., Cai Y., Ma J., Chen Y., Qin C., Cai M., et al. Panax notoginseng saponins suppress type 2 porcine reproductive and respiratory syndrome virus replication in vitro and enhance the immune effect of the live vaccine JXA1-R in piglets. Front. Vet. Sci. 2022;9:886058. doi: 10.3389/fvets.2022.886058.", "ArticleIdList": ["10.3389/fvets.2022.886058", "PMC9127999", "35619609"]}, {"Citation": "Zhao D., Chen X., Wang L., Zhang J., Lv R., Tan L., Chen Y., Tao R., Li X., Chen Y., et al. Improvement influenza vaccine immune responses with traditional Chinese medicine and its active ingredients. Front. Microbiol. 2023;14:1111886. doi: 10.3389/fmicb.2023.1111886.", "ArticleIdList": ["10.3389/fmicb.2023.1111886", "PMC10027775", "36960292"]}, {"Citation": "Chang S.H., Choi Y., Park J.A., Jung D.S., Shin J., Yang J.H., Ko S.Y., Kim S.W., Kim J.K. Anti-inflammatory effects of BT-201, an n-butanol extract of Panax notoginseng, observed in vitro and in a collagen-induced arthritis model. Clin. Nutr. 2007;26:785\u2013791. doi: 10.1016/j.clnu.2007.07.008.", "ArticleIdList": ["10.1016/j.clnu.2007.07.008", "17933436"]}, {"Citation": "Wang Y., Sun X., Xie Y., Du A., Chen M., Lai S., Wei X., Ji L., Wang C. Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-\u03baB signaling pathway. J. Ethnopharmacol. 2024;319:117135. doi: 10.1016/j.jep.2023.117135.", "ArticleIdList": ["10.1016/j.jep.2023.117135", "37689326"]}, {"Citation": "Chen J., Lu P., Liu J., Yang L., Li Y., Chen Y., Wang Y., Wan J., Zhao Y. 20(S)- Protopanaxadiol saponins isolated from Panax notoginseng target the binding of HMGB1 to TLR4 against inflammation in experimental ulcerative colitis. Phytother. Res. 2023;37:4690\u20134705. doi: 10.1002/ptr.7938.", "ArticleIdList": ["10.1002/ptr.7938", "37424151"]}, {"Citation": "Zhang Z., Zhang Y., Gao M., Cui X., Yang Y., van Duijn B., Wang M., Hu Y., Wang C., Xiong Y. Steamed Panax notoginseng attenuates anemia in mice with blood deficiency syndrome via regulating hematopoietic factors and JAK-STAT pathway. Front. Pharmacol. 2020;10:1578. doi: 10.3389/fphar.2019.01578.", "ArticleIdList": ["10.3389/fphar.2019.01578", "PMC6985777", "32038252"]}, {"Citation": "Lau A.J., Toh D.F., Chua T.K., Pang Y.K., Woo S.O., Koh H.L. Antiplatelet and anticoagulant effects of Panax notoginseng: Comparison of raw and steamed Panax notoginseng with Panax ginseng and Panax quinquefolium. J. Ethnopharmacol. 2009;125:380\u2013386. doi: 10.1016/j.jep.2009.07.038.", "ArticleIdList": ["10.1016/j.jep.2009.07.038", "19665534"]}, {"Citation": "Kwon H.W., Shin J.H., Rhee M.H., Park C.E., Lee D.H. Anti-thrombotic effects of ginsenoside Rk3 by regulating cAMP and PI3K/MAPK pathway on human platelets. J. Ginseng Res. 2023;47:706\u2013713. doi: 10.1016/j.jgr.2023.04.006.", "ArticleIdList": ["10.1016/j.jgr.2023.04.006", "PMC10721468", "38107398"]}, {"Citation": "Kwon H.W. Inhibitory effect of 20(S)-Ginsenoside Rg3 on human platelet aggregation and intracellular Ca2+ levels via cyclic adenosine monophosphate dependent manner. Prev. Nutr. Food. Sci. 2018;23:317\u2013325. doi: 10.3746/pnf.2018.23.4.317.", "ArticleIdList": ["10.3746/pnf.2018.23.4.317", "PMC6342537", "30675461"]}, {"Citation": "Xiong L., Qi Z., Zheng B., Li Z., Wang F., Liu J., Li P. Inhibitory effect of triterpenoids from Panax ginseng on coagulation factor X. Molecules. 2017;22:649. doi: 10.3390/molecules22040649.", "ArticleIdList": ["10.3390/molecules22040649", "PMC6154706", "28441767"]}, {"Citation": "Zhou Q., Jiang L., Xu C., Luo D., Zeng C., Liu P., Yue M., Liu Y., Hu X., Hu H. Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis. Thromb. Res. 2014;133:57\u201365. doi: 10.1016/j.thromres.2013.10.032.", "ArticleIdList": ["10.1016/j.thromres.2013.10.032", "24196231"]}, {"Citation": "Long L., Yu Z., Qu H., Wang N., Guo M., Zhou X., Fu C., Gao Z. Prediction of the network pharmacology-based mechanism for attenuation of atherosclerosis in apolipoprotein E knockout mice by Panax notoginseng saponins. Evid. Based Complement. Alternat. Med. 2020;2020:8574702. doi: 10.1155/2020/8574702.", "ArticleIdList": ["10.1155/2020/8574702", "PMC7193284", "32382308"]}, {"Citation": "Liu Y., Hao F., Zhang H., Cao D., Lu X., Li X. Panax notoginseng saponins promote endothelial progenitor cell mobilization and attenuate atherosclerotic lesions in apolipoprotein E knockout mice. Cell. Physiol. Biochem. 2013;32:814\u2013826. doi: 10.1159/000354484.", "ArticleIdList": ["10.1159/000354484", "24080960"]}, {"Citation": "Yang H., Liu Z., Hu X., Liu X., Gui L., Cai Z., Dai C. Protective effect of Panax Notoginseng saponins on apolipoprotein-E-deficient atherosclerosis-prone mice. Curr. Pharm. Des. 2022;28:671\u2013677. doi: 10.2174/1381612828666220128104636.", "ArticleIdList": ["10.2174/1381612828666220128104636", "35088656"]}, {"Citation": "Wang D., Lv L., Xu Y., Jiang K., Chen F., Qian J., Chen M., Liu G., Xiang Y. Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy. Biomed. Pharmacother. 2021;136:111287. doi: 10.1016/j.biopha.2021.111287.", "ArticleIdList": ["10.1016/j.biopha.2021.111287", "33485065"]}, {"Citation": "Wang C., Chen H., Ma S.T., Mao B.B., Chen Y., Xu H.N., Yu H. A network pharmacology approach for exploring the mechanisms of Panax notoginseng saponins in ischaemic stroke. Evid. Based Complement. Alternat. Med. 2021;2021:5582782. doi: 10.1155/2021/5582782.", "ArticleIdList": ["10.1155/2021/5582782", "PMC8382556", "34434246"]}, {"Citation": "Son H.Y., Han H.S., Jung H.W., Park Y.K. Panax notoginseng attenuates the infarct volume in rat ischemic brain and the inflammatory response of microglia. J. Pharmacol. Sci. 2009;109:368\u2013379. doi: 10.1254/jphs.08197FP.", "ArticleIdList": ["10.1254/jphs.08197FP", "19305121"]}, {"Citation": "Shi Y., Zhou X., Yang R., Ying S., Wang L. Panax notoginseng protects the rat brain function from traumatic brain injury by inhibiting autophagy via mammalian targeting of rapamycin. Aging. 2021;13:11207\u201311217. doi: 10.18632/aging.202790.", "ArticleIdList": ["10.18632/aging.202790", "PMC8109077", "33819197"]}, {"Citation": "Jiang T., Zhou X., Jiang H., Ying R., Zhang Z., Cai D., Wu Y., Fang H., Wang L. Efficacy of Sanqi (Radix Notoginseng) in treating cerebral hemorrhage in rats with traumatic brain injury. J. Tradit. Chin. Med. 2021;41:262\u2013269.", "ArticleIdList": ["33825406"]}, {"Citation": "Zhou N., Tang Y., Keep R.F., Ma X., Xiang J. Antioxidative effects of Panax notoginseng saponins in brain cells. Phytomedicine. 2014;21:1189\u20131195. doi: 10.1016/j.phymed.2014.05.004.", "ArticleIdList": ["10.1016/j.phymed.2014.05.004", "PMC4111966", "24916704"]}, {"Citation": "Catino S., Paciello F., Miceli F., Rolesi R., Troiani D., Calabrese V., Santangelo R., Mancuso C. Ferulic Acid Regulates the Nrf2/Heme Oxygenase-1 System and Counteracts Trimethyltin-Induced Neuronal Damage in the Human Neuroblastoma Cell Line SH-SY5Y. Front. Pharmacol. 2016;6:305. doi: 10.3389/fphar.2015.00305.", "ArticleIdList": ["10.3389/fphar.2015.00305", "PMC4705308", "26779023"]}, {"Citation": "Fetoni A.R., Paciello F., Rolesi R., Eramo S.L., Mancuso C., Troiani D., Paludetti G. Rosmarinic acid up-regulates the noise-activated Nrf2/HO-1 pathway and protects against noise-induced injury in rat cochlea. Free Radic. Biol. Med. 2015;85:269\u2013281. doi: 10.1016/j.freeradbiomed.2015.04.021.", "ArticleIdList": ["10.1016/j.freeradbiomed.2015.04.021", "25936352"]}, {"Citation": "Calabrese V., Mancuso C., Ravagna A., Perluigi M., Cini C., De Marco C., Butterfield D.A., Stella A.M. In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: Regulation by glutathione redox state. J. Neurochem. 2007;101:709\u2013717. doi: 10.1111/j.1471-4159.2006.04367.x.", "ArticleIdList": ["10.1111/j.1471-4159.2006.04367.x", "17241115"]}, {"Citation": "Mancuso C. The brain heme oxygenase/biliverdin reductase system as a target in drug research and development. Expert. Opin. Ther. Targets. 2022;26:361\u2013374. doi: 10.1080/14728222.2022.2052848.", "ArticleIdList": ["10.1080/14728222.2022.2052848", "35285395"]}, {"Citation": "Wang Z.J., Nie B.M., Chen H.Z., Lu Y. Panaxynol induces neurite outgrowth in PC12D cells via cAMP- and MAP kinase-dependent mechanisms. Chem. Biol. Interact. 2006;159:58\u201364. doi: 10.1016/j.cbi.2005.09.003.", "ArticleIdList": ["10.1016/j.cbi.2005.09.003", "16219303"]}, {"Citation": "Jiang Y., Li S., Xie X., Li H., Huang P., Li B., Huo L., Zhong J., Li Y., Xia X. Exploring the mechanism of Panax notoginseng saponins against Alzheimer\u2019s disease by network pharmacology and experimental validation. Evid. Based Complement. Alternat. Med. 2021;2021:5730812. doi: 10.1155/2021/5730812.", "ArticleIdList": ["10.1155/2021/5730812", "PMC8739172", "35003304"]}, {"Citation": "Li Z., Li H., Zhao C., Lv C., Zhong C., Xin W., Zhang W. Protective effect of notoginsenoside R1 on an APP/PS1 mouse model of Alzheimer\u2019s disease by up-regulating insulin degrading enzyme and inhibiting A\u03b2 accumulation. CNS. Neurol. Disord. Drug. Targets. 2015;14:360\u2013369. doi: 10.2174/1871527314666150225141521.", "ArticleIdList": ["10.2174/1871527314666150225141521", "25714973"]}, {"Citation": "Fang F., Chen X., Huang T., Lue L.F., Luddy J.S., Yan S.S. Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model. Biochim. Biophys. Acta. 2012;1822:286\u2013292. doi: 10.1016/j.bbadis.2011.10.004.", "ArticleIdList": ["10.1016/j.bbadis.2011.10.004", "PMC3304026", "22015470"]}, {"Citation": "Luo F.C., Wang S.D., Qi L., Song J.Y., Lv T., Bai J. Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo. J. Ethnopharmacol. 2011;133:448\u2013453. doi: 10.1016/j.jep.2010.10.017.", "ArticleIdList": ["10.1016/j.jep.2010.10.017", "20951784"]}, {"Citation": "Calabrese V., Cornelius C., Mancuso C., Pennisi G., Calafato S., Bellia F., Bates T.E., Giuffrida Stella A.M., Schapira T., Dinkova Kostova A.T., et al. Cellular stress response: A novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem. Res. 2008;33:2444\u20132471. doi: 10.1007/s11064-008-9775-9.", "ArticleIdList": ["10.1007/s11064-008-9775-9", "18629638"]}, {"Citation": "Hashimoto R., Yu J., Koizumi H., Ouchi Y., Okabe T. Ginsenoside Rb1 prevents MPP(+)-induced apoptosis in PC12 cells by stimulating estrogen receptors with consequent activation of ERK1/2, Akt and inhibition of SAPK/JNK, p38 MAPK. Evid. Based Complement. Alternat. Med. 2012;2012:693717. doi: 10.1155/2012/693717.", "ArticleIdList": ["10.1155/2012/693717", "PMC3457685", "23024694"]}, {"Citation": "Zhang X., Zhou C., Miao L., Tan Y., Zhou Y., Cheong M.S., Huang Y., Wang Y., Yu H., Cheang W.S. Panax notoginseng protects against diabetes-associated endothelial dysfunction: Comparison between ethanolic extract and total saponin. Oxid. Med. Cell. Longev. 2021;2021:4722797. doi: 10.1155/2021/4722797.", "ArticleIdList": ["10.1155/2021/4722797", "PMC8437594", "34527173"]}, {"Citation": "Du Y.G., Wang L.P., Qian J.W., Zhang K.N., Chai K.F. Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats. Chin. J. Integr. Med. 2016;22:910\u2013917. doi: 10.1007/s11655-015-2446-1.", "ArticleIdList": ["10.1007/s11655-015-2446-1", "26712211"]}, {"Citation": "Xu Y., Wang N., Tan H.Y., Li S., Zhang C., Zhang Z., Feng Y. Panax notoginseng saponins modulate the gut microbiota to promote thermogenesis and beige adipocyte reconstruction via leptin-mediated AMPK\u03b1/STAT3 signaling in diet-induced obesity. Theranostics. 2020;10:11302\u201311323. doi: 10.7150/thno.47746.", "ArticleIdList": ["10.7150/thno.47746", "PMC7532683", "33042284"]}, {"Citation": "Yang Q., Wang P., Cui J., Wang W., Chen Y., Zhang T. Panax notoginseng saponins attenuate lung cancer growth in part through modulating the level of Met/miR-222 axis. J. Ethnopharmacol. 2016;193:255\u2013265. doi: 10.1016/j.jep.2016.08.040.", "ArticleIdList": ["10.1016/j.jep.2016.08.040", "27566197"]}, {"Citation": "Hawthorne B., Lund K., Freggiaro S., Kaga R., Meng J. The mechanism of the cytotoxic effect of Panax notoginseng extracts on prostate cancer cells. Biomed. Pharmacother. 2022;149:112887. doi: 10.1016/j.biopha.2022.112887.", "ArticleIdList": ["10.1016/j.biopha.2022.112887", "35367754"]}, {"Citation": "Toh D.F., Patel D.N., Chan E.C., Teo A., Neo S.Y., Koh H.L. Anti-proliferative effects of raw and steamed extracts of Panax notoginseng and its ginsenoside constituents on human liver cancer cells. Chin. Med. 2011;6:4. doi: 10.1186/1749-8546-6-4.", "ArticleIdList": ["10.1186/1749-8546-6-4", "PMC3037355", "21255464"]}, {"Citation": "Yan Z., Yang R., Jiang Y., Yang Z., Yang J., Zhao Q., Lu Y. Induction of apoptosis in human promyelocytic leukemia HL60 cells by panaxynol and panaxydol. Molecules. 2011;16:5561\u20135573. doi: 10.3390/molecules16075561.", "ArticleIdList": ["10.3390/molecules16075561", "PMC6264185", "21716177"]}, {"Citation": "Lee C.Y., Hsieh S.L., Hsieh S., Tsai C.C., Hsieh L.C., Kuo Y.H., Wu C.C. Inhibition of human colorectal cancer metastasis by notoginsenoside R1, an important compound from Panax notoginseng. Oncol. Rep. 2017;37:399\u2013407. doi: 10.3892/or.2016.5222.", "ArticleIdList": ["10.3892/or.2016.5222", "27840961"]}, {"Citation": "Hsieh S.L., Hsieh S., Kuo Y.H., Wang J.J., Wang J.C., Wu C.C. Effects of Panax notoginseng on the metastasis of human colorectal cancer cells. Am. J. Chin. Med. 2016;44:851\u2013870. doi: 10.1142/S0192415X16500476.", "ArticleIdList": ["10.1142/S0192415X16500476", "27222068"]}, {"Citation": "Wang C.Z., Luo X., Zhang B., Song W.X., Ni M., Mehendale S., Xie J.T., Aung H.H., He T.C., Yuan C.S. Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. Cancer Chemother. Pharmacol. 2007;60:69\u201379. doi: 10.1007/s00280-006-0350-2.", "ArticleIdList": ["10.1007/s00280-006-0350-2", "PMC2657471", "17009031"]}, {"Citation": "Wang P., Cui J., Du X., Yang Q., Jia C., Xiong M., Yu X., Li L., Wang W., Chen Y., et al. Panax notoginseng saponins (PNS) inhibits breast cancer metastasis. J. Ethnopharmacol. 2014;154:663\u2013671. doi: 10.1016/j.jep.2014.04.037.", "ArticleIdList": ["10.1016/j.jep.2014.04.037", "24793216"]}, {"Citation": "He L., Chen X., Zhou M., Zhang D., Yang J., Yang M., Zhou D. Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: A randomized controlled study. Phytomedicine. 2011;18:437\u2013442. doi: 10.1016/j.phymed.2010.10.004.", "ArticleIdList": ["10.1016/j.phymed.2010.10.004", "21094030"]}, {"Citation": "Geng H., Zhang L., Xin C., Zhang C., Xie Y. Xuesaitong oral preparation as adjuvant therapy for treating acute cerebral infarction: A systematic review and meta-analysis of randomized controlled trials. J. Ethnopharmacol. 2022;285:114849. doi: 10.1016/j.jep.2021.114849.", "ArticleIdList": ["10.1016/j.jep.2021.114849", "34800648"]}, {"Citation": "Zhou D., Cen K., Liu W., Liu F., Liu R., Sun Y., Zhao Y., Chang J., Zhu L. Xuesaitong exerts long-term neuroprotection for stroke recovery by inhibiting the ROCKII pathway, in vitro and in vivo. J. Ethnopharmacol. 2021;272:113943. doi: 10.1016/j.jep.2021.113943.", "ArticleIdList": ["10.1016/j.jep.2021.113943", "33617967"]}, {"Citation": "Wu L., Song H., Zhang C., Wang A., Zhang B., Xiong C., Zhuang X., Zang Y., Li C., Fang Q., et al. Efficacy and safety of Panax notoginseng saponins in the treatment of adults with ischemic stroke in China: A randomized clinical trial. JAMA Netw. Open. 2023;6:e2317574. doi: 10.1001/jamanetworkopen.2023.17574.", "ArticleIdList": ["10.1001/jamanetworkopen.2023.17574", "PMC10282883", "37338907"]}, {"Citation": "Duan L., Xiong X., Hu J., Liu Y., Wang J. Efficacy and safety of oral Panax notoginseng saponins for unstable angina patients: A meta-analysis and systematic review. Phytomedicine. 2018;47:23\u201333. doi: 10.1016/j.phymed.2018.04.044.", "ArticleIdList": ["10.1016/j.phymed.2018.04.044", "30166105"]}, {"Citation": "Wang W., Yang L., Song L., Guo M., Li C., Yang B., Wang M., Kou N., Gao J., Qu H., et al. Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism. Biomed. Pharmacother. 2021;134:111165. doi: 10.1016/j.biopha.2020.111165.", "ArticleIdList": ["10.1016/j.biopha.2020.111165", "33370633"]}, {"Citation": "Xie Y., Wang C. Herb-drug interactions between Panax notoginseng or its biologically active compounds and therapeutic drugs: A comprehensive pharmacodynamic and pharmacokinetic review. J. Ethnopharmacol. 2023;307:116156. doi: 10.1016/j.jep.2023.116156.", "ArticleIdList": ["10.1016/j.jep.2023.116156", "36754189"]}, {"Citation": "Li Y., Lu Y.Y., Jia J., Fang M., Zhao L., Jiang Y., Shi Y., Tu P.F., Guo X.Y. A novel system for evaluating the inhibition effect of drugs on cytochrome P450 enzymes in vitro based on human-induced hepatocytes (hiHeps) Front. Pharmacol. 2021;12:748658. doi: 10.3389/fphar.2021.748658.", "ArticleIdList": ["10.3389/fphar.2021.748658", "PMC8580884", "34776966"]}, {"Citation": "Xiao J., Chen D., Lin X.X., Peng S.F., Xiao M.F., Huang W.H., Wang Y.C., Peng J.B., Zhang W., Ouyang D.S., et al. Screening of drug metabolizing enzymes for the ginsenoside compound K in vitro: An efficient anti-cancer substance originating from Panax Ginseng. PLoS ONE. 2016;11:e0147183. doi: 10.1371/journal.pone.0147183.", "ArticleIdList": ["10.1371/journal.pone.0147183", "PMC4742234", "26845774"]}, {"Citation": "Fang Z.Z., Cao Y.F., Hu C.M., Hong M., Sun X.Y., Ge G.B., Liu Y., Zhang Y.Y., Yang L., Sun H.Z. Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs) Toxicol. Appl. Pharmacol. 2013;267:149\u2013154. doi: 10.1016/j.taap.2012.12.019.", "ArticleIdList": ["10.1016/j.taap.2012.12.019", "23306165"]}, {"Citation": "Zhang J., Zhou F., Niu F., Lu M., Wu X., Sun J., Wang G. Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics. PLoS ONE. 2012;7:e35768. doi: 10.1371/journal.pone.0035768.", "ArticleIdList": ["10.1371/journal.pone.0035768", "PMC3329467", "22530069"]}, {"Citation": "Chen X.Y., Qian F., Wang Y.Y., Liu Y., Sun Y., Zha W.B., Hao K., Zhou F., Wang G.J., Zhang J.W. Ginsenoside 20(S)-Rh2 promotes cellular pharmacokinetics and intracellular antibacterial activity of levofloxacin against Staphylococcus aureus through drug efflux inhibition and subcellular stabilization. Acta Pharmacol. Sin. 2021;42:1930\u20131941. doi: 10.1038/s41401-021-00751-z.", "ArticleIdList": ["10.1038/s41401-021-00751-z", "PMC8564512", "34462563"]}, {"Citation": "Sun M., Zhu C., Long J., Lu C., Pan X., Wu C. PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat Staphylococcus aureus-induced skin infections. Drug Deliv. 2020;27:632\u2013641. doi: 10.1080/10717544.2020.1756985.", "ArticleIdList": ["10.1080/10717544.2020.1756985", "PMC7241502", "32329376"]}, {"Citation": "Zhang J., Sun Y., Wang Y., Lu M., He J., Liu J., Chen Q., Zhang X., Zhou F., Wang G., et al. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor. Eur. J. Pharmacol. 2014;740:277\u2013284. doi: 10.1016/j.ejphar.2014.07.020.", "ArticleIdList": ["10.1016/j.ejphar.2014.07.020", "25054686"]}, {"Citation": "Tian Z., Pang H., Du S., Lu Y., Zhang L., Wu H., Guo S., Wang M., Zhang Q. Effect of Panax notoginseng saponins on the pharmacokinetics of aspirin in rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2017;1040:136\u2013143. doi: 10.1016/j.jchromb.2016.12.007.", "ArticleIdList": ["10.1016/j.jchromb.2016.12.007", "27978468"]}, {"Citation": "Deng S., Wong C.K.C., Lai H.C., Wong A.S.T. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/\u03b2-catenin signaling and epithelial-to-mesenchymal transition. Oncotarget. 2017;8:25897\u201325914. doi: 10.18632/oncotarget.13071.", "ArticleIdList": ["10.18632/oncotarget.13071", "PMC5432225", "27825116"]}, {"Citation": "Chian S., Zhao Y., Xu M., Yu X., Ke X., Gao R., Yin L. Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway. Anticancer Drugs. 2019;30:838\u2013845. doi: 10.1097/CAD.0000000000000781.", "ArticleIdList": ["10.1097/CAD.0000000000000781", "31415285"]}, {"Citation": "Liu S., Huang J., Gao F., Yin Z., Zhang R. Ginsenoside RG1 augments doxorubicin-induced apoptotic cell death in MDA-MB-231 breast cancer cell lines. J. Biochem. Mol. Toxicol. 2022;36:e22945. doi: 10.1002/jbt.22945.", "ArticleIdList": ["10.1002/jbt.22945", "34783124"]}, {"Citation": "Zhu C., Wang Y., Liu H., Mu H., Lu Y., Zhang J., Huang J. Oral administration of Ginsenoside Rg1 prevents cardiac toxicity induced by doxorubicin in mice through anti-apoptosis. Oncotarget. 2017;8:83792\u201383801. doi: 10.18632/oncotarget.19698.", "ArticleIdList": ["10.18632/oncotarget.19698", "PMC5663555", "29137383"]}, {"Citation": "Wang R.R., Li T., Zhang L., Hu Z.Y., Zhou L., Shan L.T., Huang J.W., Li L. Acute developmental toxicity of Panax notoginseng in zebrafish larvae. Chin. J. Integr. Med. 2023;29:333\u2013340. doi: 10.1007/s11655-022-3302-8.", "ArticleIdList": ["10.1007/s11655-022-3302-8", "35089525"]}, {"Citation": "Tang J., Zhao M., Li Z. Immunotoxicity of Panax notoginseng in Sprague-Dawley rats. Chin. J. Public Health. 2020;36:82\u201385. doi: 10.11847/zgggws1119714.", "ArticleIdList": ["10.11847/zgggws1119714"]}, {"Citation": "Zhang K., Sun C., Hu Y., Yang J., Wu C. Network pharmacology reveals pharmacological effect and mechanism of Panax notoginseng (Burk.) F. H. Chen on reproductive and genetic toxicity in male mice. J. Ethnopharmacol. 2021;270:113792. doi: 10.1016/j.jep.2021.113792.", "ArticleIdList": ["10.1016/j.jep.2021.113792", "33422656"]}, {"Citation": "Siegel R.K. Ginseng abuse syndrome. Problems with the panacea. JAMA. 1979;241:1614\u20131615. doi: 10.1001/jama.1979.03290410046024.", "ArticleIdList": ["10.1001/jama.1979.03290410046024", "430716"]}, {"Citation": "Turck D., Castenmiller J., De Henauw S., Hirsch-Ernst K.I., Kearney J., Maciuk A., Mangelsdorf I., McArdle H.J., Naska A., Pelaez C., et al. Safety of a botanical extract derived from Panax notoginseng and Astragalus membranaceus (AstraGin\u2122) as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J. 2020;18:e06099. doi: 10.2903/j.efsa.2020.6099.", "ArticleIdList": ["10.2903/j.efsa.2020.6099", "PMC10464683", "37649518"]}]}], "History": [{"Year": "2024", "Month": "5", "Day": "7"}, {"Year": "2024", "Month": "5", "Day": "30"}, {"Year": "2024", "Month": "6", "Day": "28"}, {"Year": "2024", "Month": "7", "Day": "13", "Hour": "7", "Minute": "43"}, {"Year": "2024", "Month": "7", "Day": "13", "Hour": "7", "Minute": "42"}, {"Year": "2024", "Month": "7", "Day": "13", "Hour": "1", "Minute": "13"}, {"Year": "2024", "Month": "7", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["38999868", "PMC11242943", "10.3390/nu16132120", "nu16132120"]}}]}